使用敲除细胞株进行验证
重组
RabMAb

Anti-MGMT抗体[EPR4397] (ab108630)

发表研究结果有使用 ab108630?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab108630 被引用在 2 文献中.

  • Lai SW  et al. Differential Characterization of Temozolomide-Resistant Human Glioma Cells. Int J Mol Sci 19:N/A (2018). PubMed: 29301329
  • Niittykoski M  et al. Immunohistochemical Characterization and Sensitivity to Human Adenovirus Serotypes 3, 5, and 11p of New Cell Lines Derived from Human Diffuse Grade II to IV Gliomas. Transl Oncol 10:772-779 (2017). PubMed: 28797937

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

注册